Efficacy of rezafungin in a case of Candida spondylodiskitis
Langue
EN
Article de revue
Ce document a été publié dans
Journal of Bone and Joint Infection. 2024-01-01, vol. 9, n° 5, p. 213-215
Résumé en anglais
Rezafungin, which only requires weekly administration, is a potential candidate for difficult-to-treat infections that require long-term antimicrobial treatment, such as bone and joint infections. We report the first case ...Lire la suite >
Rezafungin, which only requires weekly administration, is a potential candidate for difficult-to-treat infections that require long-term antimicrobial treatment, such as bone and joint infections. We report the first case of spondylodiskitis successfully treated with 3 weeks of caspofungin followed by 10 weeks of rezafungin.< Réduire
Unités de recherche